Cyclic β-(1, 2)-glucan blended poly DL lactic co glycolic acid (PLGA 10:90) nanoparticles for drug delivery

Our group had previously reported the encapsulation efficiency of cyclic β-(1, 2)-glucan for various drugs. The current study is aimed at evaluating the use of glucan as a drug carrier system by blending with poly lactic-co- glycolic acid (L:G = 10:90). Nanoparticles of glucan (0.5, 5, 10 and 20 wt...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatachalam, Geetha, Venkatesan, Nandakumar, Suresh, Ganesan, Doble, Mukesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732734/
https://www.ncbi.nlm.nih.gov/pubmed/31517109
http://dx.doi.org/10.1016/j.heliyon.2019.e02289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732734/
https://www.ncbi.nlm.nih.gov/pubmed/31517109
http://dx.doi.org/10.1016/j.heliyon.2019.e02289

Ejemplares similares